首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   398篇
  免费   16篇
  国内免费   7篇
耳鼻咽喉   1篇
妇产科学   1篇
基础医学   4篇
口腔科学   2篇
临床医学   56篇
内科学   6篇
特种医学   3篇
外科学   1篇
综合类   66篇
预防医学   31篇
眼科学   141篇
药学   47篇
中国医学   62篇
  2024年   2篇
  2023年   8篇
  2022年   2篇
  2021年   5篇
  2020年   7篇
  2019年   13篇
  2018年   5篇
  2017年   13篇
  2016年   10篇
  2015年   21篇
  2014年   18篇
  2013年   28篇
  2012年   23篇
  2011年   22篇
  2010年   18篇
  2009年   33篇
  2008年   47篇
  2007年   31篇
  2006年   22篇
  2005年   24篇
  2004年   10篇
  2003年   10篇
  2002年   7篇
  2001年   8篇
  2000年   7篇
  1999年   1篇
  1998年   6篇
  1997年   3篇
  1995年   5篇
  1994年   6篇
  1993年   1篇
  1991年   2篇
  1990年   1篇
  1989年   2篇
排序方式: 共有421条查询结果,搜索用时 104 毫秒
1.
目的:探讨疏肝益气养阴法对干眼病治疗效果。方法:选取我院眼科收治的120例干眼病患者随机分为观察组和对照组,对照组采用西医玻璃酸钠滴眼药治疗,观察组根据疏肝益气养阴辩证法采用逍遥散及生脉饮治疗,比较两组患者治疗效果。结果:观察组治疗有效率为95.00%明显高于对照组80.00%治疗有效率,两组比较有统计学意义(P<0.05)。结论:疏肝益气养阴法治疗干眼病具有显著临床效果,值得在临床中推广应用。  相似文献   
2.
Objective To investigate anethol trithione therapic efficiency on dry eye. Methods It was a prospective random double-blind controlled study. Eighty cases diagnosed dry eye in Ocular Surface Out-patient Clinic of Xiamen University Affiliated Xiamen Eye Center from 2006 to 2008 were divided into two groups: anethol trithione group and control group, 40 cases in each group. Every group was then divided into two subgroups: weak dry eye subgroup, middle and severe dry eye subgroup. All groups had been added with 0.05% refresh drops. All patients had been detected and evaluated by subjective symptoms of dry eye, visual acuity,corneal fluorescent staining(F1), break-up time(BUT) and Schirmer Ⅰ test (SⅠT) at pre-therapy and 3,7,28 d of post-therapy. All groups had been compared and analyzed by F test and sample mean difference (SMD) or median difference (MD) comparison between pre-therapy and post-therapy. Results Except of tear and red eye, the other subjective symptoms of dry eye, F1, BUT and SⅠT of weak dry eye subgroup of both groups had been improved at 7 d after therapy. Only those of middle and severe dry eye subgroup of anethol trithione group had been improved at 7 d after therapy compared with those of pre-therapy: SMD=0.96 (visual tiredness), 1.26 (dry and unsmooth sensation), 0.82 (foreign body sensation), 1.28 (burning sensation), 1.05 (photophobia), 1.48 ( pain ) ; MD=0.30 (visual acuity), 4.00 (F1) ,5.00 (BUT), 5.00 (SⅠT) [F=15.30 (visual tiredness), 15.68 (dry and unsmooth sensation ), 13.56 (foreign body sensation), 20. 91 ( burning sensation ), 18.90 (photophobia), 27.22 ( pain ), 10.54 (visual acuity), 188.21 (F1) ,261.76 (BUT) ,269.05 (SⅠT) ;P<0. 05]. Those of middle and severe dry eye subgroup of control group hadn't significantly been improved at 28 d after therapy: SMD=0.10 (visual tiredness) ,0.16 (dry and unsmooth sensation) ,0.09 (foreign body sensation) ,0.38 ( burning sensation ), 0.24(photophobia) ,0.36 (pain) ,0.23 (red eye) ; MD=0.10 (visual acuity) ,0.50(F1) ,0.50(BUT), 0.50(SⅠT) [F=1.76 (visual tiredness), 1.61 (dry and unsmooth sensation), 1.02 (foreign body sensation),2.39 (burning sensation), 2.42 (photophobia), 2.73 ( pain ), 2.55 ( red eye ), 1.46 ( visual acuity) ,2.35 (F1) ,2.90 (BUT) ,2.76 (SⅠT) ; P>0.05]. SⅠT of anethol trithione group had been improved more significantly after therapy (F=13.77, P<0.05). Conclusion Anethol trithione could significantly improve middle and severe dry eye patients' symptoms and signs whose lacrimal gland function survival and it has clinical application value.  相似文献   
3.
润目地黄汤治疗干眼症35例70只眼临床观察   总被引:2,自引:0,他引:2  
干眼症是最常见的眼科疾病之一,是由多种原因导致泪膜的病理性改变,使角膜和结膜得不到正常的湿润而发生眼表上皮干涩的一组疾病的总称。除局部有刺激症状外,还可引起视物模糊或视力波动等,严重者可致视力严重下降,甚至失明。我国目前干眼症有很高的发病率,然而至今尚无特效疗法,临床治疗颇为棘手。笔者采用润目地黄汤治疗35例70只眼干眼症患者,取得较好疗效,并与用西药治疗的35例70只跟作对照观察,总结如下。  相似文献   
4.
Objective To investigate anethol trithione therapic efficiency on dry eye. Methods It was a prospective random double-blind controlled study. Eighty cases diagnosed dry eye in Ocular Surface Out-patient Clinic of Xiamen University Affiliated Xiamen Eye Center from 2006 to 2008 were divided into two groups: anethol trithione group and control group, 40 cases in each group. Every group was then divided into two subgroups: weak dry eye subgroup, middle and severe dry eye subgroup. All groups had been added with 0.05% refresh drops. All patients had been detected and evaluated by subjective symptoms of dry eye, visual acuity,corneal fluorescent staining(F1), break-up time(BUT) and Schirmer Ⅰ test (SⅠT) at pre-therapy and 3,7,28 d of post-therapy. All groups had been compared and analyzed by F test and sample mean difference (SMD) or median difference (MD) comparison between pre-therapy and post-therapy. Results Except of tear and red eye, the other subjective symptoms of dry eye, F1, BUT and SⅠT of weak dry eye subgroup of both groups had been improved at 7 d after therapy. Only those of middle and severe dry eye subgroup of anethol trithione group had been improved at 7 d after therapy compared with those of pre-therapy: SMD=0.96 (visual tiredness), 1.26 (dry and unsmooth sensation), 0.82 (foreign body sensation), 1.28 (burning sensation), 1.05 (photophobia), 1.48 ( pain ) ; MD=0.30 (visual acuity), 4.00 (F1) ,5.00 (BUT), 5.00 (SⅠT) [F=15.30 (visual tiredness), 15.68 (dry and unsmooth sensation ), 13.56 (foreign body sensation), 20. 91 ( burning sensation ), 18.90 (photophobia), 27.22 ( pain ), 10.54 (visual acuity), 188.21 (F1) ,261.76 (BUT) ,269.05 (SⅠT) ;P<0. 05]. Those of middle and severe dry eye subgroup of control group hadn't significantly been improved at 28 d after therapy: SMD=0.10 (visual tiredness) ,0.16 (dry and unsmooth sensation) ,0.09 (foreign body sensation) ,0.38 ( burning sensation ), 0.24(photophobia) ,0.36 (pain) ,0.23 (red eye) ; MD=0.10 (visual acuity) ,0.50(F1) ,0.50(BUT), 0.50(SⅠT) [F=1.76 (visual tiredness), 1.61 (dry and unsmooth sensation), 1.02 (foreign body sensation),2.39 (burning sensation), 2.42 (photophobia), 2.73 ( pain ), 2.55 ( red eye ), 1.46 ( visual acuity) ,2.35 (F1) ,2.90 (BUT) ,2.76 (SⅠT) ; P>0.05]. SⅠT of anethol trithione group had been improved more significantly after therapy (F=13.77, P<0.05). Conclusion Anethol trithione could significantly improve middle and severe dry eye patients' symptoms and signs whose lacrimal gland function survival and it has clinical application value.  相似文献   
5.
中西医对干眼病的研究进展   总被引:1,自引:0,他引:1  
干眼病是指由于泪液的量或质的异常引起的渭膜不稳定或眼表组织损害,从而导致限不适症状的一类疾病;是眼科最为常见的疾病,且发病与年龄和性别有密切的关系.老人和女性多易发病。  相似文献   
6.
目的 探讨去势雄兔干眼病模型角膜上皮细胞凋亡及相关基因表达与组织损伤的关系。方法 制作 6只去势雄兔干眼病模型 ,采用原位末端标记及免疫组织化学方法 ,对模型兔及 6只对照兔角膜上皮细胞中的凋亡细胞及Fas、FasL、Bax和bcl 2等相关基因蛋白的表达进行检测。结果 干眼病模型兔角膜上皮细胞凋亡数为 ( 5 2 3± 2 67)个 /高倍视野 ;对照兔为 ( 0 5 8± 0 13 )个 /高倍视野 (P <0 0 1)。模型兔角膜上皮细胞中 ,Fas、FasL及Bax阳性表达的细胞数均明显高于对照组 (P <0 0 1) ,与凋亡细胞数呈正相关 (r=0 78,0 82 ,0 76,P <0 0 5 ) ;bcl 2阳性表达的细胞数明显低于对照组 (P <0 0 1) ,与凋亡细胞数呈负相关 (r =-0 72 ,P <0 0 5 )。结论 去势雄兔角膜组织中上皮细胞凋亡可能是导致角膜变薄、干燥 ,进而功能丧失的原因之一 ;Fas、FasL及Bax的增加及bcl 2的减少均与促进细胞凋亡有关。  相似文献   
7.
重组人类表皮生长因子在超声乳化白内障摘除术后的应用   总被引:2,自引:0,他引:2  
目的 观察重组人类表皮生长因子 (rh EGF)滴眼液对超声乳化白内障术后泪膜的疗效。方法 随机选择两组超声乳化白内障术后患者 ,A组 (74只眼 )术后给予 rh EGF眼液 ;B组 (87只眼 )术后给予赋形剂。分别于术后第 1天、7天、15天、30天进行干眼症状、角膜荧光素染色、泪膜破裂时间 (BU T)及泪液分泌试验观察加以比较 ,并进行统计学分析。结果 术后第 7天两组患者的干眼症状、BU T、泪液分泌量及角膜荧光素着色均有好转 (P<0 .0 1) ,两组间差异无显著性 (P>0 .0 5 ) ;而术后第 15天、30天 A组各项检查结果均有反复 ,与术后第 1天比较差异无显著性 (P>0 .0 5 ) ,B组各项检查结果反复较小 ,与术后第 1天比较 ,差异有显著性 (P<0 .0 5 )。结论  rh EGF滴眼液对超声乳化白内障术后泪膜的修复有促进作用。  相似文献   
8.
近些年来的研究发现,大蒜不仅有杀菌消炎的作用,还能防治心脑血管疾病和抗癌,因此,倍受人们的青睐。可是,大蒜虽好,却并非人人皆宜,更不能天天食用。我国民间有“大蒜百利,只害一目”的说法。故患有青光眼、白内障、结膜炎、麦粒肿、干眼症等眼疾的人平时最好少吃。《本草纲目》中指出,“大蒜久食伤肝损眼”。中医认为,肝开窍于目,肝血充足可以养目,肝血虚则目失所养。患者常表现为视物不清、双目干涩。大蒜性味辛温,多吃后不仅容易导致肝血亏虚,目失所养,还会助火伤目,加重眼疾。现代医学也认为,大蒜对眼粘膜有刺激作用。所以,眼病患者在治…  相似文献   
9.
目的为腮腺导管、叶间导管转移治疗干眼病提供解剖学基础。方法用过氯乙烯为填充剂,逆行灌注腮腺导管及叶间导管制作铸型标本5具(10侧),并进行相应观察和测量。结果腮腺导管长度为(22.13±6.28)mm,内径为(3.82±1.21)mm,腮腺浅部有叶间导管3~4支,第1叶间导管长度为(37.51±1.23)mm,内径为(0.53±0.14)mm。结论腮腺导管和叶间导管解剖资料对临床腮腺导管或叶间导管转移治疗重症干眼病的手术具有参考价值。  相似文献   
10.
《陕西中医》2017,(11):1594-1595
目的:观察针刺在临床治疗干眼症的疗效。方法:将66例干眼症患者随机分为对照组和观察组各33例,对照组患者给予新泪然滴眼,观察组患者针刺治疗,进行为期1个月的临床观察,并对两组患者的临床疗效进行比较。结果:观察组总有效率为90.90%,高于对照组72.73%(P0.05)。结论:针刺治疗干眼症效果确切,明显优于单纯西药治疗。  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号